Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
Amylyx Pharmaceuticals (Nasdaq: AMLX) has announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024. The company's senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the financial results and provide company updates. Investors and interested parties can access the call by dialing +1 (800)-836-8184 (U.S. & Canada) or +1 (646)-357-8785 (international). A live audio webcast will also be available on the company's website under the Investor section. The webcast will be archived and available for replay for 90 days following the event.
Amylyx Pharmaceuticals (Nasdaq: AMLX) ha annunciato che presenterà i risultati finanziari del secondo trimestre del 2024 giovedì 8 agosto 2024. Il team di alta direzione dell'azienda condurrà una teleconferenza e un webcast audio alle 8:00 ET per discutere i risultati finanziari e fornire aggiornamenti sull'azienda. Gli investitori e le parti interessate possono accedere alla chiamata componendo +1 (800)-836-8184 (USA e Canada) o +1 (646)-357-8785 (internazionale). Sarà disponibile anche un webcast audio in diretta sul sito web dell'azienda nella sezione Investitori. Il webcast sarà registrato e disponibile per la riproduzione per 90 giorni dopo l'evento.
Amylyx Pharmaceuticals (Nasdaq: AMLX) ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el jueves 8 de agosto de 2024. El equipo directivo de la empresa llevará a cabo una llamada de conferencia y un webcast de audio a las 8:00 a.m. ET para discutir los resultados financieros y proporcionar actualizaciones sobre la empresa. Los inversores y partes interesadas pueden acceder a la llamada marcando +1 (800)-836-8184 (EE. UU. y Canadá) o +1 (646)-357-8785 (internacional). También habrá un webcast de audio en vivo disponible en el sitio web de la empresa en la sección de Inversores. El webcast se archivará y estará disponible para su reproducción durante 90 días después del evento.
Amylyx Pharmaceuticals (Nasdaq: AMLX)는 2024년 2분기 재무 결과를 발표할 것이라고 발표했습니다. 날짜는 2024년 8월 8일 목요일입니다. 회사의 고위 경영진이 동부 표준시 기준 오전 8:00에 전화 회의 및 오디오 웹캐스트를 주최하여 재무 결과에 대해 논의하고 회사 업데이트를 제공합니다. 투자자 및 관심 있는 당사자는 +1 (800)-836-8184 (미국 및 캐나다) 또는 +1 (646)-357-8785 (국제)로 전화하여 통화에 참석할 수 있습니다. 또한 회사 웹사이트의 투자자 섹션에서 실시간 오디오 웹캐스트를 이용할 수 있습니다. 이 웹캐스트는 이벤트 후 90일 동안 아카이브되어 재생할 수 있습니다.
Amylyx Pharmaceuticals (Nasdaq: AMLX) a annoncé qu'elle publiera ses résultats financiers pour le deuxième trimestre de 2024 le jeudi 8 août 2024. L'équipe de direction de l'entreprise animera une conférence téléphonique et un audio-webcast à 8h00 ET pour discuter des résultats financiers et fournir des mises à jour sur la société. Les investisseurs et les parties intéressées peuvent accéder à l'appel en composant le +1 (800)-836-8184 (États-Unis et Canada) ou le +1 (646)-357-8785 (international). Un audio-webcast en direct sera également disponible sur le site Web de l'entreprise dans la section Investisseurs. Le webcast sera archivé et disponible en replay pendant 90 jours après l'événement.
Amylyx Pharmaceuticals (Nasdaq: AMLX) hat angekündigt, dass es die finanziellen Ergebnisse des zweiten Quartals 2024 am Donnerstag, den 8. August 2024 bekannt geben wird. Das Führungsteam des Unternehmens wird um 8:00 Uhr ET eine Telefonkonferenz und einen Audio-Webcast abhalten, um die finanziellen Ergebnisse zu erörtern und Unternehmensaktualisierungen bereitzustellen. Investoren und interessierte Parteien können sich durch Wählen von +1 (800)-836-8184 (USA und Kanada) oder +1 (646)-357-8785 (international) in die Konferenz einwählen. Ein Live-Audio-Webcast wird ebenfalls auf der Unternehmenswebsite im Bereich Investoren verfügbar sein. Der Webcast wird aufgezeichnet und für 90 Tage nach der Veranstaltung zur Verfügung stehen.
- None.
- None.
To access the conference call, please dial +1 (800)-836-8184 (
About Amylyx Pharmaceuticals
Amylyx is committed to the discovery and development of new treatment options for communities with high unmet needs, including people living with serious and fatal diseases. The Company has preclinical or clinical development programs underway in neurodegenerative, neuroendocrine, and endocrine diseases. Since its founding, Amylyx has been guided by science to address unanswered questions, keeping communities at the heart and center of all decisions. Amylyx is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240805352361/en/
Media
Amylyx Media Team
+1 (857) 799-7274
amylyxmediateam@amylyx.com
Investors
Lindsey Allen
Amylyx Pharmaceuticals, Inc.
+1 (857) 320-6244
Investors@amylyx.com
Source: Amylyx Pharmaceuticals, Inc.
FAQ
When will Amylyx Pharmaceuticals (AMLX) report its Q2 2024 financial results?
What time is the Amylyx Pharmaceuticals (AMLX) Q2 2024 earnings call?
How can I access the Amylyx Pharmaceuticals (AMLX) Q2 2024 earnings call?
Where can I find the webcast for Amylyx Pharmaceuticals' (AMLX) Q2 2024 earnings call?
